A critical advance in cancer study is arising with the use of VHH fragments to restore mutated p53. This crucial tumor inhibitor protein is frequently inactivated in various kinds of malignancies, leading uncontrolled https://socialmediaentry.com/story7467107/nanobodies-reactivate-the-p53-protein-the-new-pathway-for-cancer-treatment